A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants
Condition: Chronic Graft-versus-Host Disease (cGVHD) Interventions: Drug: AMG 592; Other: Placebo Sponsor: Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
Condition: Multiple Myeloma Intervention: Other: No Intervention Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials